Literature DB >> 25195887

Structure of Mycobacterium smegmatis Eis in complex with paromomycin.

Kyoung Hoon Kim1, Doo Ri An1, Hye Jin Yoon1, Jin Kuk Yang2, Se Won Suh1.   

Abstract

The Rv2416c gene of Mycobacterium tuberculosis (Mtb) encodes the enhanced intracellular survival (Eis) protein that enhances intracellular survival of the pathogen in host macrophages during infection. The Mtb Eis protein is released into the cytoplasm of the phagocyte during intracellular infection and modulates the host immune response. It also contributes to drug resistance by acetylating multiple amine groups of aminoglycosides. Interestingly, the nonpathogenic M. smegmatis (Msm) contains a homologous eis gene (MSMEG_3513). The overall structures of Mtb Eis and Msm Eis are highly similar to each other, reflecting the high level (58%) of amino-acid sequence identity between them. Both Mtb Eis and Msm Eis are active as aminoglycoside acetyltransferases, while only Mtb Eis functions as an N(ℇ)-acetyltransferase to acetylate Lys55 of dual-specificity protein phosphatase 16 (DUSP16)/mitogen-activated protein kinase phosphatase 7 (MKP-7), leading to the suppression of host immune responses. Here, the crystal structure of Msm Eis in the paromomycin-bound form is reported, revealing detailed interactions between an aminoglycoside antibiotic and Msm Eis. The crystal structure of Msm Eis in the paromomycin-bound form has been determined at 3.3 Å resolution. This work provides potentially useful information for structure-guided discovery of Eis inhibitors as a novel antituberculosis drug against drug-resistant Mtb.

Entities:  

Keywords:  Mycobacterium smegmatis; Mycobacterium tuberculosis; aminoglycoside; drug resistance; paromomycin; tobramycin; tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25195887      PMCID: PMC4157414          DOI: 10.1107/S2053230X14017385

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  21 in total

1.  Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition.

Authors:  Wenjing Chen; Keith D Green; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2012-06-05       Impact factor: 3.162

2.  Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages.

Authors:  J Wei; J L Dahl; J W Moulder; E A Roberts; P O'Gaora; D B Young; R L Friedman
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

3.  Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis.

Authors:  J L Dahl; J Wei; J W Moulder; S Laal; R L Friedman
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 4.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

5.  Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.

Authors:  Kyoung Hoon Kim; Doo Ri An; Jinsu Song; Ji Young Yoon; Hyoun Sook Kim; Hye Jin Yoon; Ha Na Im; Jieun Kim; Do Jin Kim; Sang Jae Lee; Ki-Hye Kim; Hye-Mi Lee; Hie-Joon Kim; Eun-Kyeong Jo; Jae Young Lee; Se Won Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

6.  Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth.

Authors:  Shiping Wu; Peter F Barnes; Buka Samten; Xiuhua Pang; Sébastien Rodrigue; Saleena Ghanny; Patricia Soteropoulos; Luc Gaudreau; Susan T Howard
Journal:  Microbiology (Reading)       Date:  2009-04       Impact factor: 2.777

7.  Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling.

Authors:  Dong-Min Shin; Bo-Young Jeon; Hye-Mi Lee; Hyo Sun Jin; Jae-Min Yuk; Chang-Hwa Song; Sang-Hee Lee; Zee-Won Lee; Sang-Nae Cho; Jin-Man Kim; Richard L Friedman; Eun-Kyeong Jo
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

8.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  3 in total

1.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

2.  Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria.

Authors:  Keith D Green; Rachel E Pricer; Megan N Stewart; Sylvie Garneau-Tsodikova
Journal:  ACS Infect Dis       Date:  2015-05-04       Impact factor: 5.084

Review 3.  A Structural View of Xenophagy, a Battle between Host and Microbes.

Authors:  Do Hoon Kwon; Hyun Kyu Song
Journal:  Mol Cells       Date:  2018-01-23       Impact factor: 5.034

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.